Cargando…

Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias

Previous research has established that dopamine signals are crucial in orienting behavior to reward. Less is known, however, about the psychopharmacology of task performance under small-reward conditions as compared to large-reward conditions. The current study examined the effects of the noncompeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wisnewski, Regan G, Lauwereyns, Johan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075506/
https://www.ncbi.nlm.nih.gov/pubmed/17880723
http://dx.doi.org/10.1186/1744-9081-3-48
_version_ 1782138071007887360
author Wisnewski, Regan G
Lauwereyns, Johan
author_facet Wisnewski, Regan G
Lauwereyns, Johan
author_sort Wisnewski, Regan G
collection PubMed
description Previous research has established that dopamine signals are crucial in orienting behavior to reward. Less is known, however, about the psychopharmacology of task performance under small-reward conditions as compared to large-reward conditions. The current study examined the effects of the noncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist dizocilpine (MK-801) on reaction time (RT) in a nose-poke task with rats completing an asymmetric reward schedule. In all trials, the rats were required to poke their nose in either the left or the right peripheral hole immediately adjacent to the centre hole when the corresponding light was illuminated. Depending on the stimulus-reward mapping, however, one position was associated with a large reward, while the alternative position was associated with a small reward. Correct performance was required in every trial; if the rat did not make a correct response within 20 s, the trial was aborted, and the same stimulus was presented again on the next trial. In this way, the rat was forced to perform the same visuo-spatial discrimination task under different reward conditions. Reaction times (ms) were faster for large-reward trials than for small-reward trials, replicating previous findings. At a dosage of MK-801 (0.04 mg/kg), there was no significant influence of on RT in large-reward trials. In contrast, the same dosage of MK-801 in small-reward trials produced a decrease in RT as compared to the control condition, implying an improvement of performance. Below 0.04 mg/kg of MK-801, a steady decrease of RT in small-trials was seen as a function of dosage. Above 0.04 mg/kg of MK-801, the majority of rats failed to perform the task at all, whereas the rats that did manage to perform the criterion of 80 correct trials in a session showed no difference in RT between large- and small-reward trials. These data indicate that the systemic administration of a relatively small dosage of MK-801 facilitates performance when reward is small. It is suggested that the facilitation may be due to the reinforcement of mechanisms that work in opposition to response bias. As a corollary, the study provides a useful paradigm to study the voluntary control of unavoidable action.
format Text
id pubmed-2075506
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20755062007-11-13 Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias Wisnewski, Regan G Lauwereyns, Johan Behav Brain Funct Short Paper Previous research has established that dopamine signals are crucial in orienting behavior to reward. Less is known, however, about the psychopharmacology of task performance under small-reward conditions as compared to large-reward conditions. The current study examined the effects of the noncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist dizocilpine (MK-801) on reaction time (RT) in a nose-poke task with rats completing an asymmetric reward schedule. In all trials, the rats were required to poke their nose in either the left or the right peripheral hole immediately adjacent to the centre hole when the corresponding light was illuminated. Depending on the stimulus-reward mapping, however, one position was associated with a large reward, while the alternative position was associated with a small reward. Correct performance was required in every trial; if the rat did not make a correct response within 20 s, the trial was aborted, and the same stimulus was presented again on the next trial. In this way, the rat was forced to perform the same visuo-spatial discrimination task under different reward conditions. Reaction times (ms) were faster for large-reward trials than for small-reward trials, replicating previous findings. At a dosage of MK-801 (0.04 mg/kg), there was no significant influence of on RT in large-reward trials. In contrast, the same dosage of MK-801 in small-reward trials produced a decrease in RT as compared to the control condition, implying an improvement of performance. Below 0.04 mg/kg of MK-801, a steady decrease of RT in small-trials was seen as a function of dosage. Above 0.04 mg/kg of MK-801, the majority of rats failed to perform the task at all, whereas the rats that did manage to perform the criterion of 80 correct trials in a session showed no difference in RT between large- and small-reward trials. These data indicate that the systemic administration of a relatively small dosage of MK-801 facilitates performance when reward is small. It is suggested that the facilitation may be due to the reinforcement of mechanisms that work in opposition to response bias. As a corollary, the study provides a useful paradigm to study the voluntary control of unavoidable action. BioMed Central 2007-09-19 /pmc/articles/PMC2075506/ /pubmed/17880723 http://dx.doi.org/10.1186/1744-9081-3-48 Text en Copyright © 2007 Wisnewski and Lauwereyns; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Paper
Wisnewski, Regan G
Lauwereyns, Johan
Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias
title Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias
title_full Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias
title_fullStr Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias
title_full_unstemmed Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias
title_short Systemic dizocilpine (MK-801) facilitates performance in opposition to response bias
title_sort systemic dizocilpine (mk-801) facilitates performance in opposition to response bias
topic Short Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075506/
https://www.ncbi.nlm.nih.gov/pubmed/17880723
http://dx.doi.org/10.1186/1744-9081-3-48
work_keys_str_mv AT wisnewskiregang systemicdizocilpinemk801facilitatesperformanceinoppositiontoresponsebias
AT lauwereynsjohan systemicdizocilpinemk801facilitatesperformanceinoppositiontoresponsebias